Merck & Co to cut 6000 jobs, Moderna to cut around 500
By 
Phillip Broadwith2025-08-07T09:05:00
Both firms aiming to make significant reductions in annual costs by reorganising
US-based Merck & Co has initiated a cost-cutting plan that will see around 6000 job cuts (about 8% of its global staff) as part of an effort to reduce annual costs by $3 billion (£2.2 billion) by the end of 2027. Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 billion in annual costs by 2027